financetom
Business
financetom
/
Business
/
US FDA approves Merus' therapy to treat lung, pancreatic cancers
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Merus' therapy to treat lung, pancreatic cancers
Dec 4, 2024 1:17 PM

Dec 4 (Reuters) - The U.S. Food and Drug Administration

approved Merus NV's ( MRUS ) therapy to treat patients with types

of lung and pancreatic cancers on Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Healwell Acquires New Zealand-based Orion Health for $165 Million
Healwell Acquires New Zealand-based Orion Health for $165 Million
Dec 16, 2024
08:32 AM EST, 12/16/2024 (MT Newswires) -- Healwell AI (AIDX.TO) on Monday said it will acquire New Zealand-based Orion Health Holdings for $165 million, with a minimum $86 million in cash and the remainder in stock. The cash portion of the acquisition price will be partially funded by a bought deal private placement of 31,250 convertible debentures at $960 each...
Secure Energy Services Acquires Two Metal Recyclers for $175 Million and Releases 2025 Guidance
Secure Energy Services Acquires Two Metal Recyclers for $175 Million and Releases 2025 Guidance
Dec 16, 2024
08:26 AM EST, 12/16/2024 (MT Newswires) -- Secure Energy Services ( SECYF ) on Monday said it is expanding into waste-metal recycling, agreeing to acquire two unnamed scrap metal companies for a combined $175 million. The company also released 2025 guidance. The oilfield waste-management company said the acquisitions bring scrap-metal yards in British Columbia, Alberta and Saskatchewan with a new...
Biohaven Says BHV-1300 Achieves 'Deep Lowering' of Targeted IgG During Early-Stage Trial
Biohaven Says BHV-1300 Achieves 'Deep Lowering' of Targeted IgG During Early-Stage Trial
Dec 16, 2024
08:32 AM EST, 12/16/2024 (MT Newswires) -- Biohaven ( BHVN ) said Monday that its drug candidate BHV-1300 achieved deep lowering of targeted immunoglobulin G, or IgG, with reduction of more than 60% in the lowest subcutaneous dose tested during the current multiple ascending dose trial. The biopharmaceutical company said that the reduction in IgG occurred within hours of each...
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Federal Reserve Policy Meeting
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Federal Reserve Policy Meeting
Dec 16, 2024
08:22 AM EST, 12/16/2024 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.2% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.4% in Monday's premarket activity, as traders anticipate interest rate cuts at the Federal Reserve's policy meeting due this week. US stock futures were also higher, with S&P...
Copyright 2023-2026 - www.financetom.com All Rights Reserved